It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

Pfizer

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Japan OKs administration of Pfizer COVID-19 vaccine booster shots

National / Science & Health Nov 10, 2021

Japan OKs administration of Pfizer COVID-19 vaccine booster shots

The rollout of third injections will begin with medical personnel from December.

Pfizer applies for COVID-19 vaccine approval for kids age 5 to 11 in Japan

National Nov 10, 2021

Pfizer applies for COVID-19 vaccine approval for kids age 5 to 11 in Japan

If approved by the health ministry, Pfizer's shot will be the first to be administered to children under 11 in Japan.

South Korea to purchase 70,000 courses of new Pfizer COVID-19 pill

Asia Pacific Nov 8, 2021

South Korea to purchase 70,000 courses of new Pfizer COVID-19 pill

Pfizer has said trial results showed that its Paxlovid pill reduced by 89% the risk of hospitalization or death in some patients.

COVID-19 drugs will change the way we live with the virus

Commentary / World Nov 7, 2021

COVID-19 drugs will change the way we live with the virus

by Therese Raphael

New COVID-19 drug approvals couldn’t be timelier as hospitals face massive backlogs of delayed procedures.

Pfizer results open door to new chapter for COVID treatments

World / Science & Health | ANALYSIS Nov 6, 2021

Pfizer results open door to new chapter for COVID treatments

by Emma Court and Fiona Rutherford

The world needs an easy-to-take COVID-19 treatment. Pfizer Inc.’s and Merck & Co. Inc.’s new pills may be just that. But questions remain about their safety and how well they will work.

Pfizer develops COVID-19 pill that cuts hospitalizations and deaths by 89%

World / Science & Health Nov 5, 2021

Pfizer develops COVID-19 pill that cuts hospitalizations and deaths by 89%

by Robert Langreth

The drugmaker claims "overwhelming efficacy” and plans to submit their findings for emergency authorization as soon as possible.

Pfizer won the first round, but Moderna sees final victory ahead

World Oct 30, 2021

Pfizer won the first round, but Moderna sees final victory ahead

by Robert Langreth and Riley Griffin

Pfizer has been first across the finish line in nearly every leg of the COVID-19 vaccine race, but Moderna executives say their company’s mRNA technology gives it an advantage.

Pfizer to seek OK for use of COVID-19 shot in children in Japan age 5 to 11

National / Science & Health Oct 28, 2021

Pfizer to seek OK for use of COVID-19 shot in children in Japan age 5 to 11

by Osamu Tsukimori

The government is hinting that it will act swiftly to make the vaccine available to children in that demographic.

Japan may recommend Pfizer's COVID-19 shot over Moderna's for men under 30

National / Science & Health Oct 14, 2021

Japan may recommend Pfizer's COVID-19 shot over Moderna's for men under 30

by Osamu Tsukimori

Even as concerns grow about higher rates of myocarditis among young men who got the Moderna shot, the risk of developing the heart condition is still much lower than after getting COVID-19.

Japan secures 120 million extra Pfizer vaccine doses for next year

National Oct 8, 2021

Japan secures 120 million extra Pfizer vaccine doses for next year

The country decided in September to start administering third shots of coronavirus vaccines by the end of this year to increase protection.

Pfizer seeks U.S. COVID-19 vaccine clearance for children age 5 to 11

World Oct 8, 2021

Pfizer seeks U.S. COVID-19 vaccine clearance for children age 5 to 11

The Food and Drug Administration has set a date of Oct. 26 for its panel of outside advisers to meet and discuss the application.

China's vaccine diplomacy drive falters as recipients turn to western shots

Asia Pacific Sep 30, 2021

China's vaccine diplomacy drive falters as recipients turn to western shots

by Iain Marlow and Randy Thanthong-Knight

In the early days of COVID-19 vaccine rollouts, Chinese shots saved countless lives. But as the Western stranglehold on mRNA supplies loosens, a clear preference has emerged.

« 1 … 3 4 5 … 13 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times